DeutschNewstral
Article
Fft.com on 2020-05-27 06:25
Drug wars: how AstraZeneca overtook GSK in UK pharma
Related news
- BDrug wars: how AstraZeneca overtook GSK in UK pharmabusinessday.ng
Big pharma turns to AI to speed drug discovery, GSK signs dealmetro.us- UExplosive growth on Nasal Drug Delivery Market 2021-2027: Global Companies like J&J, BD, 3M, GSK, Merck, AstraZeneca, AptarGroupunlvrebelyell.com
- GTop 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companiesgalleonnews.com
- FGSK chief questions pharma deal boomft.com
- UOpioids Drug Market with Attractiveness, Competitive Landscape and Top Key Players (J&J, GSK, Allergan, Sun Pharma, Sanofi, Pfizer, Teva, LUPIN) | Forecasts to 2028unlvrebelyell.com
- UHyperacusis Drug Market is Ready to Set Outstanding Growth during 2021-2028 | GSK, Pfizer, Teva, Mylan, Sun Pharma, Novartis, Abbott, Bayerunlvrebelyell.com
- FAstraZeneca secures Acerta Pharma stakeft.com
- FGSK chief warns of pharma sector shake-upft.com
- FGSK consumer chief plans deal spree after split from pharmaft.com
- FDrug failure deals blow to GSK revivalft.com
- FGSK chief says lack of pharma ‘baggage’ is an advantageft.com
- FGSK fined £37m for stifling rival drugft.com
- FMedics welcome GSK meningitis B drug dealft.com
AstraZeneca sues former executive over move to rival GSKFinancial Times- FAstraZeneca cancer drug breakthroughft.com
- FWhy GSK will struggle to mount AstraZeneca-style revivalft.com
- GSK PLC: GSK bets on cough drug with $2bn deal for Canadian biotechFinancial Times
$331M deal: GSK sells rights to experimental psoriasis drugbizjournals.com